Results for:


< Back to all posts

What is the new COVID “Test to Treat” initiative in the United States?

Testing and Contact Tracing Treatments

A: President Biden announced a “Test to Treat” initiative in his State of the Union address last week. The program aims to reduce hospitalizations from COVID-19 by providing fast, free, broad access to antivirals. To be eligible, you must have confirmed mild-to-moderate COVID-19 and be at high risk for progression to severe COVID-19. TL;DR At Read more…

Who is authorized to take Evusheld, the new COVID-19 monoclonal antibody treatment?


Evusheld, a combination of two monoclonal antibodies, is a PREVENTATIVE treatment for people who have compromised immune systems AND for people with life threatening allergies to COVID-19 vaccines. The supply is very limited! COVID-19 vaccinations remain the first line treatment to prevent infection and complications. ❓What is Evusheld? This is a PREVENTATIVE treatment, meaning you Read more…

Chlorine dioxide can’t prevent or cure COVID-19 (but it can cause liver failure).

Treatments Uncertainty and Misinformation

Taking chlorine dioxide (or its relatives, such as sodium hypochlorite) does not prevent or cure COVID-19. And it is dangerous. Chlorine dioxide can cause acute kidney and liver failure, intestinal perforations with sepsis, vomiting & diarrhea, anemia, thyroid disruption, and neurological injury. It is not safe for human consumption. Not even if it comes labeled Read more…

What does it mean when hospitals are talking about “Crisis Standards of Care?”


A: As many places see a significant surge in COVID-19 cases, hospitals and resources become strained. Crisis standards of care represent a big change from usual healthcare made necessary by a major disaster. Crisis standards help guide decisions that must be made in extreme scarcity of resources (including staff, stuff, and space). Crisis standards of Read more…

💥 #GoodNewsTues: Clinical Trial Edition! 💥


Pfizer’s antiviral regimen appears highly effective at keeping high-risk COVID-19 patients alive and out of the hospital, and demonstrates no safety concerns in the final reporting from its pivotal randomized controlled trial. These findings are especially welcome in the wake of deep disappointment surrounding the lackluster final trial results of Merck’s antiviral. But before we Read more…

Breaking news on the treatment front!


We Nerdy Girls are abuzz about the a-mazing clinical trial data reported out by Merck on its investigational antiviral pill. Here’s what we know so far: ➡️ Merck’s antiviral pill reduced by 50% the chances that newly diagnosed COVID-19 patients would be hospitalized over a 1-month period relative to placebo ➡️ No red flags raised Read more…